Vera Therapeutics Long Term Debt

Vera Therapeutics (VERA) currently reports a long-term debt of $75M as of June 2026. That compares with $77M in the prior-year period — down 1.9% year over year. Use the charts on this page to explore Vera Therapeutics's long-term debt history and peer comparisons.

Vera Therapeutics's long-term debt decreased from $77M to $75M — a 1.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vera Therapeutics reported $75M in long-term debt as of June 2026. That compares with $77M in the prior-year period — down 1.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $75M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vera Therapeutics, and consider following VERA for alerts when major investors trade the stock.

Vera Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $75M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VERA with unrelated industries.